Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study

2020 The Lancet 1,768 citations

Keywords

MedicineProstate cancerBiopsyProstateHistopathologyProspective cohort studyRadiologyReceiver operating characteristicRadiation therapyNuclear medicineCancerInternal medicinePathology

Affiliated Institutions

Related Publications

Publication Info

Year
2020
Type
article
Volume
395
Issue
10231
Pages
1208-1216
Citations
1768
Access
Closed

External Links

Citation Metrics

1768
OpenAlex

Cite This

Michael S. Hofman, Nathan Lawrentschuk, Roslyn J. Francis et al. (2020). Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study. The Lancet , 395 (10231) , 1208-1216. https://doi.org/10.1016/s0140-6736(20)30314-7

Identifiers

DOI
10.1016/s0140-6736(20)30314-7